<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03650517</url>
  </required_header>
  <id_info>
    <org_study_id>IDIVAL CI18/27</org_study_id>
    <nct_id>NCT03650517</nct_id>
  </id_info>
  <brief_title>Minimally Invasive Right Colectomy Anastomosis Study</brief_title>
  <acronym>MIRCAST</acronym>
  <official_title>A Prospective Observational Multi-center 4 Cohort Study Comparing Robotic Assisted and Laparoscopic Invasive Right Colectomy and Intracorporeal Anastomosis Versus Extracorporeal Anastomosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Instituto de Investigación Marqués de Valdecilla</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Instituto de Investigación Marqués de Valdecilla</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Right colectomy (hemicolectomy) involves the removal of the cecum, the ascending colon, the
      hepatic flexure, the first one-third of the transverse colon, part of the terminal ileum, and
      the associated regional fat and lymph nodes, and is the accepted treatment for malignant
      neoplasms of the right colon.

      A minimally invasive approach is commonly used for right colectomy, with studies reporting
      reduced complications, less blood loss, and hospital stay when compared to an open approach.

      However, there remains controversy regarding whether robotic assistance is advantageous for
      this technique and whether an intracorporeal (ICA) or extracorporeal anastomosis (ECA) is
      best.

      MIRCAST is a prospective, observational, international, multi-center, 4-parallel-cohorts
      study. Sites or surgeons will select a cohort of the study for which they are qualified. Four
      cohorts will be the subject of study:

        1. Robotic Right Colectomy with ICA

        2. Robotic Right Colectomy with ECA

        3. Laparoscopic Right Colectomy with ICA

        4. Laparoscopic Right Colectomy with ECA

      All patient assessments will be done according to the sites standard of care. Parameters
      routinely recorded during right colectomy surgery will be collected prospectively. Enrolled
      subjects will undergo assessments at the following intervals: pre-operative, operative,
      discharge, 30 days, 3 months, 1 year and 2 years post-surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      MIRCAST study is an observational, prospective, parallel cohorts, international, multi-center
      to compare robotic assisted and laparoscopic minimally invasive right colectomy, and
      intracorporeal anastomosis versus extracorporeal anastomosis.

      The research is coordinated by Marcos Gómez Ruiz MD PhD from Hospital Universitario Marqués
      de Valdecilla in Santander, Spain; the sponsorship is performed by Fundacion Instituto de
      Investigación Marqués de Valdecilla (IDIVAL). The European Society of Coloproctology (ESCP)
      endorses MIRCAST Study and will run a quality audit/independent monitoring of the study.

      The objectives of study are to compare of the peri-operative complications after robotic
      assisted and laparoscopic minimally invasive right colectomy with intracorporeal anastomosis
      versus extracorporeal anastomosis.

      To Identify potential benefits of robotic assisted procedures for right colon resections.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 1, 2018</start_date>
  <completion_date type="Anticipated">December 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Surgical wound infection</measure>
    <time_frame>30 days</time_frame>
    <description>(CDC definition [Health Protection Agency. Surveillance of Surgical Site Infection in England: October 1997-September 2005. London: Health Protection Agency; 2006): Superficial incisional, affecting the skin and subcutaneous tissue. These infections may be indicated by localised (Celsian) signs such as redness, pain, heat or swelling at the site of the incision or by the drainage of pus.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Clavien Dindo Complication</measure>
    <time_frame>30 days</time_frame>
    <description>Complications according to Clavien Dindo Classification.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Overall Survival</measure>
    <time_frame>2 years</time_frame>
    <description>The length of time from either the date of diagnosis or the start of treatment for a disease, such as cancer, that patients diagnosed with the disease are still alive</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Disease Free Survival (DFS)</measure>
    <time_frame>2 years</time_frame>
    <description>Length of time after primary treatment for a cancer ends that the patient survives without any signs or symptoms of that cancer.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Local Recurrence rate</measure>
    <time_frame>2 years</time_frame>
    <description>Rate of cancer that has recurred at or near the same place as the original (primary) tumor</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Distant metastases rate</measure>
    <time_frame>2 years</time_frame>
    <description>Rate of Cancer that has spread from the original (primary) tumor to distant organs or distant lymph nodes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of Unplanned Conversions to open surgery</measure>
    <time_frame>7 days</time_frame>
    <description>When anything apart of the anastomosis had to be done through the laparotomy. If the anastomosis is not completely performed in an intracorporeal approach, the case is considered also converted</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Operative time (min)</measure>
    <time_frame>7 days</time_frame>
    <description>Operative time from skin to skin in minutes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complete mesocolic excision (CME)</measure>
    <time_frame>30 days</time_frame>
    <description>Complete Mesocolic Excision is defined as complete resection of the mesocolon with its anatomical envelope. Anatomical report should include any defect on CME specimen (Hohenberger W, Weber K., Matzel K., Papadopoulost T., Merkel S. Standardized surgery for colonic cancer: complete mesocolic excision and central ligation - technical notes and outcome. Colorectal Disease 11, 354-365 2008. doi:10.1111/j.1463-1318.2008.01735.x)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Harvested Lymph Nodes</measure>
    <time_frame>30 days</time_frame>
    <description>Number of harvested Lymph nodes according to the definitive pathological report.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>R0 Resection</measure>
    <time_frame>30 days</time_frame>
    <description>Rate of resection without any affected margins during the surgical procedure.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of Stay (LOS, days)</measure>
    <time_frame>3 months</time_frame>
    <description>In hospital stay of the patient from the day that they are admitted before surgery to the day that they are fit to leave the hospital after the procedure.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ventral hernia (assessed 1&amp; 2 years after the right colectomy)</measure>
    <time_frame>1 and 2 years after the procedure</time_frame>
    <description>Incidence of ventral hernia 1 year after the procedure and 2 years after the procedure at the laparotomy site.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life Questionnaire (QLQ) of the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-C30</measure>
    <time_frame>3 months and 1 year after the procedure</time_frame>
    <description>Quality of Life Questionnaire (QLQ) of the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-C30 Score 3 months and 1 year after the procedure.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life Questionnaire (QLQ) of the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-CR29</measure>
    <time_frame>3 months and 1 year after the procedure</time_frame>
    <description>Quality of Life Questionnaire (QLQ) of the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-CR29 Score 3 months and 1 year after the procedure.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>C-Reactive Protein value (CRP) days 1 &amp; 3 postoperative</measure>
    <time_frame>1 and 3 postoperative days.</time_frame>
    <description>CRP values on postoperative day 1 and 3.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Procalcitonine (PCT) days 1, 3 &amp; 5 postoperative</measure>
    <time_frame>1, 3 and 5 postoperative days</time_frame>
    <description>PCT values on postoperative dates 1, 3 and 5</description>
  </other_outcome>
  <other_outcome>
    <measure>Time to deambulation</measure>
    <time_frame>30 days</time_frame>
    <description>Time until patient gets out of bed and engages in light activity (such as sitting, standing, or walking)</description>
  </other_outcome>
  <other_outcome>
    <measure>Return to work/activity</measure>
    <time_frame>30 days and 3 months</time_frame>
    <description>o Time to start working/activity at patient´s job again</description>
  </other_outcome>
  <other_outcome>
    <measure>Pain evaluation</measure>
    <time_frame>Postoperative days 1, 3 and 5</time_frame>
    <description>Visual analogue scale (VAS) scores at postoperative days. Scores will range from 0 to 10 (0 no pain and 10 a pain you would rather prefer to die).</description>
  </other_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">1200</enrollment>
  <condition>Colorectal Cancer</condition>
  <condition>Anastomotic Complication</condition>
  <condition>Colectomy</condition>
  <arm_group>
    <arm_group_label>Robotic Right Colectomy with ICA</arm_group_label>
    <description>Robot-assisted surgery (RAS), allows many types of complex MIS procedures using robotic systems to aid in surgical procedures providing more precision, flexibility and control than is possible with other MIS techniques.
Intracorporeal anastomosis: when the anastomosis is performed inside the abdominal cavity with a laparoscopic or robotic technique. A Pfannenstiel incision will be done exclusively for specimen extraction.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Robotic Right Colectomy with ECA</arm_group_label>
    <description>Robot-assisted surgery (RAS), allows many types of complex MIS procedures using robotic systems to aid in surgical procedures providing more precision, flexibility and control than is possible with other MIS techniques.
Extracorporeal anastomosis: when the anastomosis is performed by pulling out the bowel through a laparotomy wherever that laparotomy is performed.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Laparoscopic Right Colectomy with ICA</arm_group_label>
    <description>Laparoscopic surgery, also called minimally invasive surgery (MIS), or keyhole surgery, is a surgical technique in which operations are performed far from their location through small incisions (usually 0.5-1.5 cm) elsewhere in the body.
Intracorporeal anastomosis: when the anastomosis is performed inside the abdominal cavity with a laparoscopic or robotic technique. A Pfannenstiel incision will be done exclusively for specimen extraction.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Laparoscopic Right Colectomy with ECA</arm_group_label>
    <description>Laparoscopic surgery, also called minimally invasive surgery (MIS), or keyhole surgery, is a surgical technique in which operations are performed far from their location through small incisions (usually 0.5-1.5 cm) elsewhere in the body.
Extracorporeal anastomosis: when the anastomosis is performed by pulling out the bowel through a laparotomy wherever that laparotomy is performed.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Extracorporeal Anastomosis</intervention_name>
    <description>Anastomosis is performed by pulling out the bowel through a laparotomy wherever that laparotomy is performed.</description>
    <arm_group_label>Laparoscopic Right Colectomy with ECA</arm_group_label>
    <arm_group_label>Robotic Right Colectomy with ECA</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Intracorporeal Anastomosis</intervention_name>
    <description>Anastomosis is performed inside the abdominal cavity with a laparoscopic or robotic technique</description>
    <arm_group_label>Laparoscopic Right Colectomy with ICA</arm_group_label>
    <arm_group_label>Robotic Right Colectomy with ICA</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Robotic Surgery</intervention_name>
    <description>Procedure is performed using robotic instruments</description>
    <arm_group_label>Robotic Right Colectomy with ECA</arm_group_label>
    <arm_group_label>Robotic Right Colectomy with ICA</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Laparoscopic Surgery</intervention_name>
    <description>Procedure is performed using standard laparoscopic instruments</description>
    <arm_group_label>Laparoscopic Right Colectomy with ECA</arm_group_label>
    <arm_group_label>Laparoscopic Right Colectomy with ICA</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Right colon tumor with indication for right colectomy
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 years or older.

          -  Right colon tumor with indication for right colectomy (benign or malignant disease)

          -  Patient has a life expectancy of at least 12 weeks

          -  Patients with adequate performance status (Eastern Cooperative Oncology Group Scale
             score of ≤2)

          -  Patient has signed and dated the Informed consent before patient inclusion in the
             study

        Exclusion Criteria:

          -  Patient with a comorbid illness or condition that would preclude the use of surgery

          -  Patients with cT4b tumors

          -  Patients unwilling to comply with all follow-up study requirements

          -  Patient undergoing emergency procedures

          -  Planned colonic surgery along with major concomitant procedures (e.g. liver
             resections, other intestinal resections)

          -  Metastatic disease

          -  Pregnant or suspected pregnancy

          -  Inflammatory Bowel Disease (Crohn´s Disease or Ulcerative Colitis)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marcos Gómez Ruiz, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Universitario Marqués de Valdecilla, IDIVAL</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Galo Peralta, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Instituto de Investigación Marqués de Valdecilla</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Marcos Gómez Ruiz, MD PhD</last_name>
    <phone>0034942202520</phone>
    <phone_ext>73733</phone_ext>
    <email>marcos.gomez@scsalud.es</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Lucía Lavín Alconero, BSc PhD</last_name>
    <email>eclinicos5@idival.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>County Hospital Požega</name>
      <address>
        <city>Požega</city>
        <country>Croatia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital of Southern Denmark</name>
      <address>
        <city>Aabenraa</city>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Zealand University Hospital</name>
      <address>
        <city>Køge</city>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Kanta-Hämeen Keskussairaala</name>
      <address>
        <city>Hämeenlinna</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Arto Turunen</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kymenlaakso Central Hospital</name>
      <address>
        <city>Kotka</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pälvi Vento</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Päijät-Häme Central Hospital</name>
      <address>
        <city>Lahti</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jyrki Kössi</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Oulu University Hospital</name>
      <address>
        <city>Oulu</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tero Rautio</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Seinäjoki Central Hospital</name>
      <address>
        <city>Seinäjoki</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tarja Pinta</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Haut-Lévèque- CHU</name>
      <address>
        <city>Bordeaux</city>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>CHU Estaing</name>
      <address>
        <city>Clermont-Ferrand</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Anne DUBOIS</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>ICM - Institut Régional du Cancer de Montpellier</name>
      <address>
        <city>Montpellier</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philippe ROUANET</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHRU de Strasbourg Hôpital Civil</name>
      <address>
        <city>Strasbourg</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Benoit ROMAIN Benoit</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHRU Nancy Brabois</name>
      <address>
        <city>Vandœuvre-lès-Nancy</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Laurent BRESLER</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medizinische Hochschule Hannover</name>
      <address>
        <city>Hannover</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Markus Winny</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Eurokliniki Athinou</name>
      <address>
        <city>Athens</city>
        <state>Athina</state>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thalia Petropoulou</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>AOU-Careggi</name>
      <address>
        <city>Florence</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Andrea Coratti</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ospedale La Misericordia</name>
      <address>
        <city>Grosseto</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paolo Pietro Bianchi, MD PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>IEO - European Institute of Oncology</name>
      <address>
        <city>Milan</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wanda Luisa Petz</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Policlínico Agostino Gemelli</name>
      <address>
        <city>Roma</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dominico D´Ugo</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Humanitas Research Hospital</name>
      <address>
        <city>Rozzano</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antonino Spinelli</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>IRCCS Istituto di Candiolo</name>
      <address>
        <city>Torino</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Dario RIBERO</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centro Hospitalar de Leiria</name>
      <address>
        <city>Leiria</city>
        <country>Portugal</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Nuno Rama</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital General Universitario de Elche</name>
      <address>
        <city>Elche</city>
        <state>Alicante</state>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antonio Arroyo Sebastián, MD</last_name>
    </contact>
    <investigator>
      <last_name>Antonio Arroyo Sebastián</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Central de Asturias</name>
      <address>
        <city>Oviedo</city>
        <state>Asturias</state>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nuria Truan Alonso</last_name>
    </contact>
    <investigator>
      <last_name>Nuria Truan Alonso</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Marqués de Valdecilla</name>
      <address>
        <city>Santander</city>
        <state>Cantabria</state>
        <zip>39008</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marcos Gómez Ruiz, MD</last_name>
    </contact>
    <investigator>
      <last_name>Carmen Cagigas Fernández</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Julio José Del Castillo Diego</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Joaquin Alonso Martín</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lidia Cristobal Poch</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Manuel Gómez Fleitas</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marcos Gómez Ruiz</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Vall d´hebron</name>
      <address>
        <city>Barcelona</city>
        <state>Cataluña</state>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eloy Espin</last_name>
    </contact>
    <investigator>
      <last_name>Franco Marinello</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Donostia</name>
      <address>
        <city>San Sebastián</city>
        <state>Pais Vasco</state>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Carlos Placer Galán</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>José María Enriquez Navascues</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Complejo hospitalario de Torrecardenas</name>
      <address>
        <city>Almería</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pedro Antonio Sanchez Fuentes, MD</last_name>
    </contact>
    <investigator>
      <last_name>Angel Reina Duarte</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Francisco Rubio Gil</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Manuel Ferrer Marquez</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital de León</name>
      <address>
        <city>León</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vicente Simó Fernández</last_name>
    </contact>
    <investigator>
      <last_name>Vicente Simó Fernández</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Clínico San Carlos</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mauricio García Alonso, MD</last_name>
    </contact>
    <investigator>
      <last_name>Oscar Cano Valderrama</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mauricio García Alonso</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario 12 de octubre</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eduardo Rubio Gonzalez</last_name>
    </contact>
    <investigator>
      <last_name>Oscar García Villar</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>María Labalde Martinez</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Eduardo Rubio Gonzalez</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Portsmouth Hospital NHS Trust</name>
      <address>
        <city>Portsmouth</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jim Kahn</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Croatia</country>
    <country>Denmark</country>
    <country>Finland</country>
    <country>France</country>
    <country>Germany</country>
    <country>Greece</country>
    <country>Italy</country>
    <country>Portugal</country>
    <country>Spain</country>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>July 16, 2018</study_first_submitted>
  <study_first_submitted_qc>August 26, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 28, 2018</study_first_posted>
  <last_update_submitted>September 24, 2019</last_update_submitted>
  <last_update_submitted_qc>September 24, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 25, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Laparoscopic</keyword>
  <keyword>Robotic</keyword>
  <keyword>Right colon tumor</keyword>
  <keyword>Anastomosis</keyword>
  <keyword>Intracorporeal</keyword>
  <keyword>Extracorporeal</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

